Navigation Links
LSU receives $2 million from NIH for biomedical sciences training for underrepresented students
Date:12/2/2013

LSU Professor Graca Vicente was recently awarded a grant of more than $2 million from the National Institutes of Health, or NIH, to continue Phase III of the Initiative for Maximizing Student Development, or IMSD. She is the Charles H. Barr Distinguished Professor of Chemistry and Professor of Chemotherapy/Materials in the Department of Chemistry at LSU.

"The renewal of Phase III of the IMSD Program is giving us the opportunity to continue to provide research training and career development for LSU students," said Vicente. "It is also an opportunity to build and promote faculty collaborations, develop partnerships with other training programs and increase minority representation in Ph. D. and post-Ph. D. programs across the world."

Vicente serves at the director of IMSD, which provides research training, academic development and career opportunities in the biomedical and behavioral sciences to underrepresented minority graduate and undergraduate students at LSU.

LSU is one of a select group of universities in the United States to establish this program. IMSD has been supported since 2004 by the National Institutes of Health and Phase III, the third round of funding for IMSD, is funded through 2018. Phase I included a $546,000 award for four years (2004-2008) and Phase II was a competitive renewal for the following four years of $970,000 thousand (2009-2013).

Phase III differs from Phases I and II because, in addition to supporting the research of LSU undergraduate students, it also supports graduate students conducting research in the biomedical or behavioral sciences.

IMSD works to consistently produce graduates who rank among the most highly talented, motivated and productive research scientists in the nation. The LSU IMSD Scholars pursue successful research careers and leadership positions, and are among the most sought-after candidates nationwide for entrance into Ph.D. or post-Ph.D. programs.

"The IMSD Program has very special value to me because I am myself a minority Latino/Hispanic woman in the basic sciences," said Vicente. "One of my personal goals has always been to increase minority representation in research, particularly in the basic sciences."

She received her doctoral degree in chemistry from the University of California-Davis in 1990. She completed postdoctoral fellowships at the University of Bourgogne in France (1991), the University of Geneva in Switzerland (1991-1993) and ITQB (Research Institute) in Portugal (1993).

Her research interests include synthesis and investigation of physiochemical and biological properties of new fluorescent pyrrole-based compounds and their development for application in biology and medicine, such as bio-imaging, diagnosis, photodynamic therapy and boron neutron capture therapy of cancer.


'/>"/>

Contact: Ashley Berthelot-Arceneaux
aberth4@lsu.edu
225-578-3870
Louisiana State University
Source:Eurekalert

Related biology news :

1. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
2. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
3. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
4. Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award
5. Carnegies Wolf B. Frommer receives Bogorad Award for Excellence in Plant Biology
6. UC Riverside plant cell biologist receives top scientific honor
7. UC Riverside receives grant for global health and development research
8. Washington University receives $8 million to lead international childhood malnutrition effort
9. SRI Sarnoffs Iris on the MoveĀ® N-Glanceā„¢ Identification System Receives Lenel Factory Certification
10. SF State biology department receives $1.5 million to support science teaching
11. Dr. Karen Lloyd receives WHOIs Holger W. Jannasch Visiting Scholar Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... ... February 16, 2017 , ... Avomeen & MichBio will be hosting a BioMixer ... at Avomeen Analytical Services (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers are ... opportunity to interact with peers, make new connections and talk bio biz. , Cost:, ...
(Date:2/16/2017)... Feb. 16, 2017 Research and ... Biology: Global Markets" report to their offering. ... ... genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, ... assembly, genome editing, bioinformatics and specialty media) and enabled ...
(Date:2/16/2017)... , Feb. 16, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, today ... 1a financing and entered into a $5 million ... intends to use the capital for general corporate ... advancements in the treatment of serious diseases treated ...
(Date:2/16/2017)... YORK , Feb. 16, 2017 Paradigm ... Series B financing, adding an additional $3M from New ... Mesa Verde Venture Partners and other strategic partners at ... towards further accelerating commercial adoption of their flagship Paradigm ... and expanding the Paradigm cancer registry. ...
Breaking Biology Technology: